Innovation & intellectual property · 24/02/2014Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension for Lawsonia Intracellularis Bacterin Vaccine Patent
Summary
The U.S. Patent and Trademark Office has issued an order granting a one-year interim extension under the Patent Term Adjustment Act for U.S. Patent No. 5,610,059, which covers the Monovalent Lawsonia Intracellularis Bacterin Vaccine